JO
BGMD

John Overdeck’s BG MEDICINE INC COM STK NEW BGMD Stock Holding History

John Overdeck’s Portfolio BGMD Stock Details BGMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,081
Closed -$31K – 2518
2014
Q1 		$31K Buy
+4,081
New +$22.5K ﹤0.01% 1932

Other funds holding BGMD

FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
GE
General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

John Overdeck's BGMD Position: Q2 2014 in Review

John Overdeck sold out of BG MEDICINE INC COM STK NEW (BGMD) in Q2 2014, closing a stake of 4,081 shares — an estimated $31K sold.

John Overdeck first reported a position in BGMD in Q1 2014 and held it in 1 quarter. The position peaked at $31K in Q1 2014. 29 funds tracked by Wall St. Rank hold BGMD as of Q2 2014.

  • John Overdeck reported no remaining BG MEDICINE INC COM STK NEW position as of Q2 2014 after selling out during the quarter.
  • John Overdeck sold 4,081 BG MEDICINE INC COM STK NEW shares in Q2 2014, an estimated $31K.
  • John Overdeck first reported a position in BG MEDICINE INC COM STK NEW in Q1 2014 and held it in 1 quarter.
  • John Overdeck's BG MEDICINE INC COM STK NEW position peaked at $31K in Q1 2014.
  • 29 funds tracked by Wall St. Rank held BG MEDICINE INC COM STK NEW as of Q2 2014.

Based on Two Sigma Investments's 13F filing for Q2 2014, filed 14 Aug 2014.